Saturday 17 October 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
291.67
5.52
−1.86%
Follow UFPT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 17.05% | 17.17% | 17.82% | 18.31% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 5 | 5 | 6 | |
| 10.98% | 10.42% | 10.64% | 10.40% | ||
ROIC |
10.29% | 10.15% | 10.44% | 10.65% | |
Return on Tangible Assets |
30.96% | 30.43% | 33.28% | 34.73% | |
Average Days of Receivables |
67.82 | 61.48 | 53.42 | 53.10 | |
Free Cash Flow per Share |
7.95 | 9.01 | 10.26 | 11.34 | |
Free Cash Flow |
61.50 | 69.55 | 79.03 | 87.47 | |
Capital Expenditures |
(10.08) | (11.75) | (12.87) | (12.02) | |
| Other line items | |||||
Cash ROIC |
10.20% | 11.40% | 13.31% | 15.01% | |
Accounts Receivable Turnover |
6.19 | 6.10 | 6.78 | 6.70 | |
Accounts Payable Turnover |
16.24 | 15.01 | 17.81 | 15.35 | |
Inventory Turnover |
4.88 | 4.75 | 4.96 | 4.89 | |
Average Days of Payables |
26.64 | 23.79 | 20.50 | 25.14 | |
Days of Inventory on Hand |
80.89 | 78.64 | 73.32 | 73.56 | |
Tax Rate |
(0.18) | (0.18) | (0.17) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.27% | 13.10% | 12.85% | 12.56% | |
Share Based Compensation of Revenue |
1.63% | 1.54% | 1.47% | 1.42% | |
Interest Coverage |
12.40 | 10.60 | 9.42 | 8.27 | |
Operating CF/Net income |
0.99 | 1.18 | 1.35 | 1.48 | |
Depreciation/Fixed assets |
0.26 | 0.25 | 0.24 | 0.24 | |
Capex/Depreciation |
(0.51) | (0.60) | (0.67) | (0.64) | |
Revenue per Share |
81.61 | 78.86 | 78.23 | 77.54 | |
Operating CF per Share |
9.25 | 10.53 | 11.93 | 12.90 | |
Capex per Share |
(1.30) | (1.52) | (1.67) | (1.56) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates